AxoGen, Inc. receives David J. Gury Company of the Year Award from BioFlorida

Award recognizes company’s contribution to Florida’s life sciences industry

ALACHUA, Fla., Oct. 18, 2017 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, has received the BioFlorida David J. Gury Company of the Year Award. The award, presented this week at the 20th anniversary BioFlorida Annual Conference, recognizes a company that has achieved significant milestones and has contributed to the growth of Florida's life sciences industry.

“Our platform for nerve repair can play an important role in helping surgeons improve the quality of life for patients with nerve damage,” said Karen Zaderej, president and CEO of AxoGen. “AxoGen has successfully evolved, expanding laterally from an initial niche product in a new market to a comprehensive nerve repair platform in an emerging market. We are grateful for the partnerships we have enjoyed on this journey; the University of Florida, the communities of Gainesville and Alachua, BioFlorida, and many others have provided support as we built a growing and sustainable life sciences business.”

AxoGen, founded in Alachua, FL in 2002 with technology licensed from the University of Florida, is the leading company focused specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. AxoGen is redefining the way damaged peripheral nerves are repaired by developing new nerve repair products and expanded applications that bring meaningful solutions to current clinical challenges.

Under the leadership of Karen Zaderej, AxoGen has experienced 26 consecutive quarters of year-over-year double-digit growth and reported a record $15.2 million in revenue in Q2 2017, representing 46 percent growth over the prior year.

“AxoGen is a stand-out example of a Florida-based life science company that is changing health care around the world and inspiring our industry through ingenuity, innovation, and compelling financial and clinical results,” said Nancy K. Bryan, president and CEO of BioFlorida. “We are delighted to honor AxoGen with this award and look forward to their continued success.”

BioFlorida is the voice of Florida’s life sciences industry, representing nearly 6,000 establishments and research organizations in the biopharmaceutical, medical technology and bioagriculture sectors that collectively employ nearly 83,000 Floridians. The David J. Gury Company of the Year Award is named in honor of David Gury, one of the founding directors of BioFlorida.

About AxoGen
AxoGen (AXGN) is a global leader in innovative surgical solutions for peripheral nerve injuries. AxoGen is the leading company focused specifically on the science, development and commercialization of technologies for peripheral nerve regeneration and repair. We are passionate about restoring nerve function and quality of life to patients with peripheral nerve injuries by providing innovative, clinically proven and economically effective repair solutions for surgeons and health care providers. Peripheral nerves provide the pathways for both motor and sensory signals throughout the body. Every day, people suffer traumatic injuries or undergo surgical procedures that impact the function of their peripheral nerves. Damage to a peripheral nerve can result in the loss of muscle or organ function, the loss of sensory feeling, or the initiation of pain.